Endogenous Methylarginines Regulate Neuronal Nitric-oxide Synthase and Prevent Excitotoxic Injury

This publication has 30 references indexed in Scilit:

• Involvement of accumulated endogenous NOS inhibitors and decreased NOS activity in the impaired neurogenic relaxation of the rabbit proximal urethra with ischaemia
  British Journal of Pharmacology, 2001
• Plasma Concentration of Asymmetric Dimethylarginine, an Endogenous Inhibitor of Nitric Oxide Synthase, Is Elevated in Monkeys With Hyperhomocyst(e)inemia or Hypercholesterolemia
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
• Asymmetric Dimethylarginine Increases Mononuclear Cell Adhesiveness in Hypercholesterolemic Humans
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
• Novel Mechanism for Endothelial Dysfunction
  Circulation, 1999
• Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial Dysfunction
  Circulation, 1998
• Elevated endogenous nitric oxide synthase inhibitor in schizophrenic plasma may reflect abnormalities in brain nitric oxide production
  Neuroscience Letters, 1996
• NMDA-dependent superoxide production and neurotoxicity
  Nature, 1993
• Inactivation of macrophage nitric oxide synthase activity by NG-Methyl-L-arginine
  Biochemical and Biophysical Research Communications, 1991
• Quantitative and kinetic characterization of nitric oxide and EDRF released from cultured endothelial cells
  Biochemical and Biophysical Research Communications, 1988
• Sodium N‐Methyl‐D‐glucamine Dithiocarbamate and Cadmium Intoxication
  Acta Pharmacologica et Toxicologica, 1984